Last week, Home Health Care News highlighted widespread reports of home health therapy layoffs and visit reductions following the implementation of the Patient-Driven Groupings Model (PDGM). While therapy-visit reductions are tied to a number of factors, some stakeholders have specifically called attention to what they see as an over-reliance on predictive analytics tools and an […]
Axxess, CellTrak expand EVV partnership Dallas-based Axxess, a home health technology company, plans to expand its partnership with CellTrak to provide electronic visit verification (EVV) to more home health and home care providers in the United States. Schaumburg, Illinois-based CellTrak is a software company that provides care delivery management solutions used by more than 4,000 […]
With the implementation of the Patient-Driven Groupings Model (PDGM) less than four months away, agencies continue to prepare for the biggest reimbursement change the industry has seen in about 20 years. Technology and data providers are rolling out tools to help agencies rise to the challenge. Most recently, WellSky launched a new data analytics solution […]
For home health agencies wondering how they’ll fare under the upcoming Patient-Driven Groupings Model (PDGM), data is likely the closest thing they’ll find to a crystal ball. Data can help agencies determine where they stand under the revolutionary new reimbursement model and — in many cases — even guide them to operate more efficiently come […]
Encompass Health (NYSE: EHC) has made a minority investment in predictive analytics firm Medalogix. Regulatory changes and staffing shortages driving the need for increased efficiency in home health and hospice motivated the investment, according to Encompass Health Chief Strategy Officer Luke James. “As we look out into the future, [we’re excited about] having a direct […]
Amedisys Inc. (Nasdaq: AMED) has long been a home health powerhouse. Under the leadership of CEO Paul Kusserow, however, the Baton Rouge, Louisiana-based provider is steadily building expansive hospice and personal care footprints as well. For proof, look no further than the industry-shaping Compassionate Care Hospice deal for $340 million. Part of Amedisys’s hospice-centric strategy […]
In recent years, the U.S. health care system’s shift toward value-based reimbursement has given home health providers cause to test all sorts of approaches aimed at reducing hospital readmission rates or preventing unnecessary trips to the emergency department. Predictive analytics-driven telehealth outreach programs that risk-stratify patients based on medical vulnerability and other factors can be […]
Encompass Health Corp. (NYSE: EHC) saw its home health-related revenue jump in the first quarter of 2019, driven primarily by volume and pricing gains. The Birmingham, Alabama-based company expects more of the same moving forward — even as the home health industry marches toward the Patient-Driven Groupings Model (PDGM). Overall, net operating revenues for Encompass […]
Amedisys Inc. (Nasdaq: AMED) took its first major step into the world of predictive analytics in August when it announced a minority investment in home health-focused data science firm Medalogix. The Baton Rouge, Louisiana-based company has now started to reap the rewards of that investment. During the past few months, Amedisys has been fine-tuning its […]
2018 was a banner year for the Medicare-certified home health care industry. Big providers got even larger through creative mergers and acquisitions. Admissions and utilization numbers held strong. New telehealth opportunities started to emerge. And, in general, revenues remained high. The upcoming year brings much uncertainty, however, with the main culprit being the Patient-Driven Groupings […]
By continuing to use the site, you agree to the use of cookies. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this. For more information, see our cookie policy
